Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
Increased capability to produce medicines for challenging diseases including cancer
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Subscribe To Our Newsletter & Stay Updated
